GondolaBio
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3160 Porter Dr Ste 250, Palo Alto, Calif...Website
www.gondolabio.comRevenue
<$5 MillionIndustry
About GondolaBio
GondolaBio, founded in 2024 as a spinout of BridgeBio Pharma, aims to develop next-generation therapeutics for genetic diseases with substantial backing of $300 million in private financing. The company focuses on leveraging advanced biological research to create innovative medicines addressing significant unmet needs across various therapeutic areas. Their projects range from early discovery stages to clinical development, targeting a diverse array of modalities. GondolaBio seeks to improve the lives of patients by providing breakthroughs in treatment options for genetic disorders.Explore more
SIC Code 28,283NAICS Code 32,325Show more
GondolaBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
GondolaBio Tech Stack
A closer look at the technologies used by GondolaBio
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GondolaBio
Sign Up For FreeTo access detailed company insights
GondolaBio, founded in 2024 as a spinout of BridgeBio Pharma, aims to develop next-generation therapeutics for genetic diseases with substantial backing of $300 million in private financing. The company focuses on leveraging advanced biological research to create innovative medicines addressing significant unmet needs across various therapeutic are... Read More
